FDA — authorised 10 October 2014
- Application: NDA205834
- Marketing authorisation holder: GILEAD SCIENCES INC
- Status: supplemented
🇺🇸 Ledipasvir and sofosbuvir in United States
FDA authorised Ledipasvir and sofosbuvir on 10 October 2014
Marketing authorisation
Other Infectious Disease / Virology approved in United States
Frequently asked questions
Is Ledipasvir and sofosbuvir approved in United States?
Yes. FDA authorised it on 10 October 2014.
Who is the marketing authorisation holder for Ledipasvir and sofosbuvir in United States?
GILEAD SCIENCES INC holds the US marketing authorisation.